Axios · U.S. · US Congress · Axios
Zoom in: The poll indicates that bipartisan majorities support expanding prescription drug discount services like TrumpRx and
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
Premiums and copays are enough of a concern that 26% of those polled say they'd be or somewhat likely to shop for a new health plan this year because of rising costs.
Key facts
- Methodology: This Axios/Ipsos Poll was conducted June 12-15, 2026, by Ipsos' KnowledgePanel®
- The cost concerns are particularly hitting price-sensitive individuals ages 30-49, parents of kids under 18 and those with household income below $50,000
- Health care policy was pivotal in the 2018 and 2022 midterms
- The poll also found that many Americans remain unaware of how GLP-1 obesity drugs work, even as prescriptions for the injectables and pills surge
Summary
Majorities of Americans say they're more likely to vote for candidates in November who support ideas to lower their health costs, according to the latest Axios-Ipsos American Health Index. Their support for ideas across the political spectrum, from renewing Affordable Care Act subsidies to expanding direct sales of prescription drugs, shows the power of voters' demands for relief. This year, they're converging into a demand for health care affordability as consumers seek relief anywhere to offset high prices for gas, groceries and other basic needs. About half of Americans say measures aimed at drug and insurance affordability will probably influence who they'll vote for. More than 6 in 10 respondents say they support direct-to-consumer drug sales that could reduce some out-of-pocket costs.